|
Lot/serial number was manufactured prior to udi compliance date; therefore, only a di is provided evaluation of the customer issue included a review of the complaint text, in-house testing, a search for similar complaints, and a review of labeling.Return material was not available from the customer.In-house testing performed across multiple architect csystem analyzers demonstrated that glucose reagent lot 48090uq08 is performing within specifications.Tracking and trending did not identify an adverse trend.Labeling was reviewed and found to be adequate.Based on the available information no product deficiency of the architect tsh reagent, ln 03l82, lot 48090uq08, was identified.
|